Pacific Biosciences Of California (PACB) Shares Outstanding (Weighted Average) (2010 - 2026)

Pacific Biosciences Of California's Shares Outstanding (Weighted Average) history runs 17 years deep, the most recent figure standing at $305.8 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Weighted Average) rose 3.02% year-over-year to $305.8 million; the TTM figure through Mar 2026 stood at $305.8 million (up 3.02% YoY), while the FY2025 annual figure was $300.0 million, up 9.28% from the prior year.
• Shares Outstanding (Weighted Average) was $305.8 million for Q1 2026 at Pacific Biosciences Of California, up from $300.0 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $305.8 million in Q1 2026 to a low of $222.3 million in Q1 2022.
• Historically, Shares Outstanding (Weighted Average) has averaged $264.0 million across 5 years, with a median of $269.6 million in 2024.
• The sharpest annual moves came in 2022 and 2026: Shares Outstanding (Weighted Average) soared 1907.35% in 2022, then advanced 3.02% in 2026.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $224.6 million in 2022, then gained by 12.95% to $253.6 million in 2023, then gained by 8.22% to $274.5 million in 2024, then rose by 9.28% to $300.0 million in 2025, then advanced by 1.95% to $305.8 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $305.8 million (Q1 2026), $300.0 million (Q4 2025), and $299.3 million (Q3 2025), per Business Quant data.